Scientists Link Chronic Fatigue Syndrome to Dysfunction in the Brain’s Waste-Clearing System
Scientists in Australia have reported the first direct link between chronic fatigue syndrome and dysfunction in the brain's waste-clearing network, known as the glymphatic system. The findings could help explain why patients experience profound exhaustion, cognitive difficulties, and disrupted sleep.
The preliminary study, published in Frontiers in Neuroscience, used advanced MRI scans to evaluate glymphatic function in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Researchers found clear evidence that this waste-clearing system functioned less efficiently in patients than in healthy volunteers.
What the Glymphatic System Does
The glymphatic system is a relatively recent discovery in neuroscience and is believed to function as the brain's internal waste-disposal network. It circulates cerebrospinal fluid through channels surrounding blood vessels, helping remove toxic proteins, dead cells, and metabolic waste products.
Evidence from animal studies suggests that this process is most active during deep sleep, when waves of cerebrospinal fluid move through brain tissue. Impaired glymphatic function has previously been linked to neurological disorders including Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
A Closer Look at the New Study
Researchers at Griffith University scanned the brains of 31 people diagnosed with ME/CFS and compared the results with those of 27 healthy control participants. Rather than using invasive tracers injected into cerebrospinal fluid, the team employed a non-invasive MRI technique that estimates glymphatic activity by measuring how cerebrospinal fluid diffuses into tiny perivascular spaces surrounding blood vessels.
Although this method is less direct than tracer-based imaging, it can be performed safely and repeatedly. Previous research has used the same technique to identify altered glymphatic function in patients with neurodegenerative and vascular diseases, making it a promising tool for studying brain waste clearance in living people.
Right-Side Brain Changes and Symptoms
The researchers found that participants with ME/CFS showed reduced glymphatic function specifically in the right hemisphere of the brain. This asymmetric pattern resembles findings reported in other neurological disorders, including temporal lobe epilepsy, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).
Importantly, the severity of right-sided glymphatic impairment correlated with symptom severity. Patients who reported greater sleep disruption and more pronounced cognitive difficulties, commonly referred to as "brain fog," also demonstrated greater dysfunction of the brain's waste-clearing system on MRI scans.
What It Could Mean for Patients
The findings add to growing evidence that ME/CFS has a biological basis involving immune, inflammatory, and neurological changes. If the glymphatic system functions inefficiently, waste products and potentially harmful molecules may accumulate within the brain, contributing to chronic inflammation in the central nervous system.
Such a mechanism could help explain not only persistent fatigue and cognitive impairment but also the observed overlap between ME/CFS and post-viral conditions, including some cases of long COVID. However, the current study does not explain why the right hemisphere appears to be more affected or how this asymmetry develops.
Limitations and Next Research Steps
The authors emphasize that this was a small, preliminary study and cannot establish a cause-and-effect relationship. Larger multicenter studies will be needed to confirm the findings, improve imaging techniques, and determine whether glymphatic dysfunction could eventually serve as a diagnostic biomarker for ME/CFS.
Future research is expected to investigate whether interventions that improve sleep quality or target vascular and inflammatory pathways can enhance glymphatic function. Long-term follow-up studies may also determine whether impaired brain waste clearance predicts disease progression or response to treatment.
For now, the findings strengthen the growing body of evidence suggesting that sleep and efficient brain waste removal are fundamental to neurological health. As scientists continue to better understand the glymphatic system, they hope these discoveries will lead to more accurate diagnosis and, ultimately, more effective treatments for people living with ME/CFS.